rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2001-4-6
|
pubmed:abstractText |
This study was undertaken to determine the activity and toxicity of regional chemotherapy using an isolated thoracic perfusion (ITP) technique as second-line treatment for patients with advanced and recurrent non-small cell lung cancer (NSCLC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0748-7983
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright Harcourt Publishers Limited.
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
190-5
|
pubmed:dateRevised |
2009-7-24
|
pubmed:meshHeading |
pubmed-meshheading:11289757-Adult,
pubmed-meshheading:11289757-Aged,
pubmed-meshheading:11289757-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11289757-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11289757-Chemotherapy, Cancer, Regional Perfusion,
pubmed-meshheading:11289757-Cisplatin,
pubmed-meshheading:11289757-Clinical Trials as Topic,
pubmed-meshheading:11289757-Combined Modality Therapy,
pubmed-meshheading:11289757-Female,
pubmed-meshheading:11289757-Fluorouracil,
pubmed-meshheading:11289757-Humans,
pubmed-meshheading:11289757-Lung Neoplasms,
pubmed-meshheading:11289757-Male,
pubmed-meshheading:11289757-Middle Aged,
pubmed-meshheading:11289757-Mitomycin,
pubmed-meshheading:11289757-Neoplasm Recurrence, Local,
pubmed-meshheading:11289757-Survival Rate,
pubmed-meshheading:11289757-Tomography, X-Ray Computed,
pubmed-meshheading:11289757-Vinblastine
|
pubmed:year |
2001
|
pubmed:articleTitle |
Regional plus systemic chemotherapy: an effective treatment in recurrent non-small cell lung cancer.
|
pubmed:affiliation |
Department of Oncologic Surgery, Carl von Hess Hospital, Hammelburg, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|